Skip to Main Content

Author Details

Jos?? Manuel Calder??n-Monta??o
Faculty of Pharmacy, University of Seville
2010
56
19
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36827184DDX47, MeCP2, and other functionally heterogeneous factors protect cells from harmful R loops.Cell Rep2023
38069364Repurposing Study of 4-Acyl-1-phenylaminocarbonyl-2-substituted-piperazine Derivatives as Potential Anticancer Agents-In Vitro Evaluation against Breast Cancer Cells.Int J Mol Sci2023
37765439Evaluation of Anticancer Activity of 76 Plant Species Collected in Andalusia (Spain) against Lung Cancer Cells.Plants (Basel)2023
36902018Artificial Diets with Altered Levels of Sulfur Amino Acids Induce Anticancer Activity in Mice with Metastatic Colon Cancer, Ovarian Cancer and Renal Cell Carcinoma.Int J Mol Sci2023
36900331Artificial Diets with Selective Restriction of Amino Acids and Very Low Levels of Lipids Induce Anticancer Activity in Mice with Metastatic Triple-Negative Breast Cancer.Cancers (Basel)2023
35331830pH-temperature dual-sensitive nucleolipid-containing stealth liposomes anchored with PEGylated AuNPs for triggering delivery of doxorubicin.Int J Pharm2022
35841721Chirality influence on the cytotoxic properties of anionic chiral bis(N-heterocyclic carbene)silver complexes.J Inorg Biochem2022
36551206Overexpressed c-Myc Sensitizes Cells to TH1579, a Mitotic Arrest and Oxidative DNA Damage Inducer.Biomolecules2022
36555771Manipulation of Amino Acid Levels with Artificial Diets Induces a Marked Anticancer Activity in Mice with Renal Cell Carcinoma.Int J Mol Sci2022
36014884Artificial Diets Based on Selective Amino Acid Restriction versus Capecitabine in Mice with Metastatic Colon Cancer.Nutrients2022
34199018Cholesterol Levels Affect the Performance of AuNPs-Decorated Thermo-Sensitive Liposomes as Nanocarriers for Controlled Doxorubicin Delivery.Pharmaceutics2021
35052721In Vitro Anticancer Activity and Mechanism of Action of an Aziridinyl Galactopyranoside.Biomedicines2021
34686002Screening for Selective Anticancer Activity of 65 Extracts of Plants Collected in Western Andalusia, Spain.Plants (Basel)2021
34593524MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia.Cancer Res2021
34236855Carbohydrate-Based NK1R Antagonists with Broad-Spectrum Anticancer Activity.J Med Chem2021
32155797Anticancer Activities of Meroterpenoids Isolated from the Brown Alga <i>Cystoseira usneoides</i> against the Human Colon Cancer Cells HT-29.Foods2020
32290492Meroterpenoids from the Brown Alga <i>Cystoseira usneoides</i> as Potential Anti-Inflammatory and Lung Anticancer Agents.Mar Drugs2020
29842791Screening for selective anticancer activity of plants from Grazalema Natural Park, Spain.Nat Prod Res2019
29289868Avoiding the ingestion of cytotoxic concentrations of ethanol may reduce the risk of cancer associated with alcohol consumption.Drug Alcohol Depend2018
30151707A 30-s exposure to ethanol 20% is cytotoxic to human keratinocytes: possible mechanistic link between alcohol-containing mouthwashes and oral cancer.Clin Oral Investig2018
30375672Selective cytotoxic activity and DNA damage by an epoxyalkyl galactopyranoside.Drug Dev Res2018
30416680The Cockayne syndrome protein B is involved in the repair of 5-AZA-2'-deoxycytidine-induced DNA lesions.Oncotarget2018
29669914Are most cancer cases a consequence of an immune deficiency caused by thymic involution?Proc Natl Acad Sci U S A2018
28067901Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies.Nat Med2017
28145708Identification of Triazolothiadiazoles as Potent Inhibitors of the dCTP Pyrophosphatase 1.J Med Chem2017
29142246A comprehensive structural, biochemical and biological profiling of the human NUDIX hydrolase family.Nat Commun2017
28508636Piperazin-1-ylpyridazine Derivatives Are a Novel Class of Human dCTP Pyrophosphatase 1 Inhibitors.J Med Chem2017
28862438Correction to Piperazin-1-ylpyridazine Derivatives Are a Novel Class of Human dCTP Pyrophosphatase 1 Inhibitors.J Med Chem2017
28710964Design, synthesis and biological studies of a library of NK1-Receptor Ligands Based on a 5-arylthiosubstituted 2-amino-4,6-diaryl-3-cyano-4H-pyran core: Switch from antagonist to agonist effect by chemical modification.Eur J Med Chem2017
28732309Zebularine induces replication-dependent double-strand breaks which are preferentially repaired by homologous recombination.DNA Repair (Amst)2017
26771665Discovery of the First Potent and Selective Inhibitors of Human dCTP Pyrophosphatase 1.J Med Chem2016
28009306Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities.Cell Rep2016
27399778Cells Deficient in the Fanconi Anemia Protein FANCD2 are Hypersensitive to the Cytotoxicity and DNA Damage Induced by Coffee and Caffeic Acid.Toxins (Basel)2016
26748709Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities.Cell Rep2016
25736686Bufalin is a steroid receptor coactivator inhibitor-letter.Cancer Res2015
26197498Antiproliferative Activity of seco-Oxacassanes from Acacia schaffneri.Nat Prod Commun2015
25899283In vitro and in vivo evaluation of ο⁹-tetrahidrocannabinol/PLGA nanoparticles for cancer chemotherapy.Int J Pharm2015
25698441Does the Nerium oleander extract PBI-05204 have potential for pancreatic cancer therapy?Invest New Drugs2015
23752179The in vivo antitumor activity of cardiac glycosides in mice xenografted with human cancer cells is probably an experimental artifact.Oncogene2014
25299679Sulforaphane homologues: Enantiodivergent synthesis of both enantiomers, activation of the Nrf2 transcription factor and selective cytotoxic activity.Eur J Med Chem2014
25074383The PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2'-deoxycytidine lesions.Nucleic Acids Res2014
24895612Evaluating the cancer therapeutic potential of cardiac glycosides.Biomed Res Int2014
24934343Effect of DNA repair deficiencies on the cytotoxicity of drugs used in cancer therapy - a review.Curr Med Chem2014
23681185Comment on 'Quiescence and γH2AX in neuroblastoma are regulated by ouabain/Na,K-ATPase': ouabain and cancer.Br J Cancer2013
24177365Aziridines from alkenyl-β-D-galactopyranoside derivatives: Stereoselective synthesis and in vitro selective anticancer activity.Eur J Med Chem2013
23824549A hydroalcoholic extract from the leaves of Nerium oleander inhibits glycolysis and induces selective killing of lung cancer cells.Planta Med2013
23867916Alpha, beta-unsaturated lactones 2-furanone and 2-pyrone induce cellular DNA damage, formation of topoisomerase I- and II-DNA complexes and cancer cell death.Toxicol Lett2013
23638972Selective cytotoxic activity of new lipophilic hydroxytyrosol alkyl ether derivatives.J Agric Food Chem2013
236095375-Aza-2'-deoxycytidine causes replication lesions that require Fanconi anemia-dependent homologous recombination for repair.Nucleic Acids Res2013
22594470Pro-oxidant natural products as anticancer agents.Curr Drug Targets2012
  • 1 - 50 of 56

Recommended Authors

Roswell Park Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Jilin University
Career Start Year 2005
Number of shared co-authors 0
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 2003
Number of shared co-authors 0
Post Graduate Institute of Medical Education and Research
Career Start Year 2003
Number of shared co-authors 0
Chalmers University of Technology
Career Start Year 2000
Number of shared co-authors 0
Princess Margaret Cancer Centre
Career Start Year 1999
Number of shared co-authors 0
Kaohsiung Medical University
Career Start Year 1998
Number of shared co-authors 0
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences
Career Start Year 1998
Number of shared co-authors 0
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 1997
Number of shared co-authors 0
University of Illinois at Urbana-Champaign
Career Start Year 1995
Number of shared co-authors 1
Middle East Technical University
Career Start Year 1994
Number of shared co-authors 0
University of Franca
Career Start Year 1994
Number of shared co-authors 0
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 0
Career Start Year 1992
Number of shared co-authors 0
Princess Margaret Cancer Centre
Career Start Year 1989
Number of shared co-authors 0
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1988
Number of shared co-authors 0
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University
Career Start Year 1987
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1987
Number of shared co-authors 0
University of Turin
Career Start Year 1985
Number of shared co-authors 0
National Cancer Institute
Career Start Year 1978
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1977
Number of shared co-authors 0
Moores Cancer Center, university of california san diego
Career Start Year 1977
Number of shared co-authors 0
Institute of Biomedical Engineering (IBME), University of Oxford
Career Start Year 1976
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1975
Number of shared co-authors 0
The Institute of Cancer Research
Career Start Year 1974
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 1974
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1972
Number of shared co-authors 0
The University of Texas Health Science Center at San Antonio
Career Start Year 1971
Number of shared co-authors 0
PHusis Therapeutics Inc.
Career Start Year 1970
Number of shared co-authors 1
National Cancer Institute
Career Start Year 1945
Number of shared co-authors 0

Collaborators

The University of Sheffield
Co-authored papers 14
Karolinska Institutet
Co-authored papers 6
Karolinska Institutet
Co-authored papers 6
Department of Pharmacy, Uppsala University
Co-authored papers 4
Stockholm University
Co-authored papers 2
Stockholm University
Co-authored papers 2
Karolinska Institutet
Co-authored papers 2
Karolinska Institute
Co-authored papers 2
Stockholm University
Co-authored papers 2
Uppsala University
Co-authored papers 1
Wellcome Sanger Institute
Co-authored papers 1
Umea University
Co-authored papers 1
Stockholm University
Co-authored papers 1
KTH Royal Institute of Technology
Co-authored papers 1
Uppsala University
Co-authored papers 1
Uppsala University
Co-authored papers 1
University of Ljubljana
Co-authored papers 1
Harvard Medical School
Co-authored papers 1
Karolinska Institutet
Co-authored papers 1
Stockholm University
Co-authored papers 1
Department of Pharmaceutical Biosciences, Uppsala University
Co-authored papers 1
Uppsala University
Co-authored papers 1
Division of Clinical Genetics, Lund University
Co-authored papers 1
Co-authored papers 1
Karolinska Institute
Co-authored papers 1
Stockholm University
Co-authored papers 1
Stanford University
Co-authored papers 1